Literature DB >> 194130

Tumors of the major salivary glands.

E M Skolnik, M Friedman, S Becker, G A Sisson, G A Keyes.   

Abstract

Tumors of the major salivary glands are reviewed according to classification, location, surgical procedure and end results. Our data of the incidence of benign and malignant tumors show that the most commonly involved area is the parotid gland and the most frequent is of the mixed variety. In the parotid region 80 percent are benign and 20 percent are malignant; whereas, in the submandibular gland, the malignant and benign tumors are equally distributed. The need for an extensive surgical attack and inclusion of contiguous structure is dictated by the nature of the malignant disease. The role of postoperative irradiation is discussed as is the indication for neck dissection. Management of the facial nerve, relative to malignant tumors of the parotid gland, is considered in detail.

Entities:  

Mesh:

Year:  1977        PMID: 194130     DOI: 10.1288/00005537-197706000-00001

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

1.  Carcinoma of the major salivary glands.

Authors:  S E Afify; J D Maynard
Journal:  Ann R Coll Surg Engl       Date:  1992-05       Impact factor: 1.891

2.  Primary malignant neoplasms of the lacrimal gland.

Authors:  J E Wright; G E Rose; A Garner
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

Review 3.  Lymphoepithelial-like carcinoma of the parotid gland: a case report and a brief review of the western literature.

Authors:  Maria R Ambrosio; Maria G Mastrogiulio; Aurora Barone; Bruno J Rocca; Carmine Gallo; Stefano Lazzi; Lorenzo Leoncini; Cristiana Bellan
Journal:  Diagn Pathol       Date:  2013-07-15       Impact factor: 2.644

4.  S100A4 overexpression proves to be independent marker for breast cancer progression.

Authors:  Nawfal I Ismail; Gurjeet Kaur; Hasnah Hashim; Mohammed S Hassan
Journal:  Cancer Cell Int       Date:  2008-09-05       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.